RS64650B1 - Solubilisate with curcumin, boswellia, and xanthohumol - Google Patents

Solubilisate with curcumin, boswellia, and xanthohumol

Info

Publication number
RS64650B1
RS64650B1 RS20230894A RSP20230894A RS64650B1 RS 64650 B1 RS64650 B1 RS 64650B1 RS 20230894 A RS20230894 A RS 20230894A RS P20230894 A RSP20230894 A RS P20230894A RS 64650 B1 RS64650 B1 RS 64650B1
Authority
RS
Serbia
Prior art keywords
solubilisate
xanthohumol
boswellia
curcumin
Prior art date
Application number
RS20230894A
Other languages
Serbian (sr)
Inventor
Dariush Behnam
Original Assignee
Aquanova Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2017/067382 external-priority patent/WO2019011415A1/en
Priority claimed from DE102017115496.5A external-priority patent/DE102017115496A1/en
Priority claimed from PCT/EP2017/067381 external-priority patent/WO2019011414A1/en
Application filed by Aquanova Ag filed Critical Aquanova Ag
Publication of RS64650B1 publication Critical patent/RS64650B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/324—Boswellia, e.g. frankincense
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484—Glycyrrhiza (licorice)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
RS20230894A 2017-07-11 2018-07-11 Solubilisate with curcumin, boswellia, and xanthohumol RS64650B1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
PCT/EP2017/067382 WO2019011415A1 (en) 2017-07-11 2017-07-11 Solubilisate with curcumin, xanthohumol and licorice root extract
DE102017115496.5A DE102017115496A1 (en) 2017-07-11 2017-07-11 Licorice root extract Solubilisate
PCT/EP2017/067381 WO2019011414A1 (en) 2017-07-11 2017-07-11 Solubilisate with curcumin and boswellia
EP18737623.1A EP3651804B1 (en) 2017-07-11 2018-07-11 Solubilisate with curcumin, boswellia, and xanthohumol
PCT/EP2018/068729 WO2019011954A1 (en) 2017-07-11 2018-07-11 Solubilisate with curcumin, boswellia, and xanthohumol

Publications (1)

Publication Number Publication Date
RS64650B1 true RS64650B1 (en) 2023-10-31

Family

ID=62837944

Family Applications (3)

Application Number Title Priority Date Filing Date
RS20230894A RS64650B1 (en) 2017-07-11 2018-07-11 Solubilisate with curcumin, boswellia, and xanthohumol
RS20230868A RS64636B1 (en) 2017-07-11 2019-07-10 Solubilisate with curcumin and at least the cannabinoid thc as a further active agent
RS20230897A RS64642B1 (en) 2017-07-11 2019-07-10 Solubilisate comprising curcumin and at least one cannabinoid as a further active agent

Family Applications After (2)

Application Number Title Priority Date Filing Date
RS20230868A RS64636B1 (en) 2017-07-11 2019-07-10 Solubilisate with curcumin and at least the cannabinoid thc as a further active agent
RS20230897A RS64642B1 (en) 2017-07-11 2019-07-10 Solubilisate comprising curcumin and at least one cannabinoid as a further active agent

Country Status (19)

Country Link
US (6) US11344509B2 (en)
EP (2) EP3651805B1 (en)
JP (1) JP2020529974A (en)
KR (1) KR20200029002A (en)
CN (2) CN111163806A (en)
BR (1) BR112020000398A2 (en)
CA (2) CA3148455A1 (en)
DK (3) DK3651804T5 (en)
ES (3) ES2965739T3 (en)
FI (2) FI3651804T3 (en)
HR (3) HRP20231160T1 (en)
HU (4) HUE063380T2 (en)
MX (2) MX2021000339A (en)
PL (3) PL3651805T3 (en)
PT (2) PT3651804T (en)
RS (3) RS64650B1 (en)
RU (2) RU2752078C1 (en)
UA (1) UA125552C2 (en)
WO (3) WO2019011955A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111163806A (en) 2017-07-11 2020-05-15 阿奎诺瓦股份公司 Solubilized product comprising curcumin, boswellia and xanthohumol
DK3820527T3 (en) 2018-07-11 2023-09-25 Aquanova Ag XANTHOHUMOL SOLUBILISATE
DE202019104734U1 (en) * 2019-08-29 2020-12-01 Aquanova Ag Folic acid solubilisate
WO2023282783A1 (en) * 2021-07-09 2023-01-12 Акционерное Общество "Акванова Рус" Micellized solution of an active ingredient based on liquorice extract, method of producing and using same
WO2023224134A1 (en) * 2022-05-16 2023-11-23 주식회사 다미래 Composition for improving cognitive ability using water soluble curcumin and boswellia extracts

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07165588A (en) 1993-12-13 1995-06-27 Tsumura & Co Cerebral function improver
US5744161A (en) 1995-02-24 1998-04-28 Sabinsa Corporation Use of piperine as a bioavailability enhancer
US5629351A (en) 1995-04-13 1997-05-13 Council Of Scientific & Industrial Research Boswellic acid compositions and preparation thereof
DE50211163D1 (en) 2002-04-30 2007-12-20 Cognis Ip Man Gmbh Microcapsules with anti-acne agents
ES2258200T3 (en) 2002-12-18 2006-08-16 Dohler Gmbh DRINK CONTAINING XANTOHUMOL.
WO2005092352A1 (en) 2004-03-26 2005-10-06 Jianzhong Zhu A Producing Method and Applications of Chinese Medicine Liposome Preparation for Treating Viral Hepatitis B and Preventing and Curing Fibration of Liver Cell
US20080220102A1 (en) 2005-07-08 2008-09-11 Dariush Behnam Solubilsation Products of an Active Ingredient Extract
DE102006024911A1 (en) 2006-05-24 2007-11-29 Aquanova Ag Solubilizate of plant extract that contains active agent, useful as additive for e.g. cosmetics, pharmaceuticals and foods, includes water and emulsifier
WO2007056242A1 (en) 2005-11-07 2007-05-18 Murty Pharmaceuticals, Inc. Improved delivery of tetrahydrocannabinol
WO2007058480A1 (en) 2005-11-16 2007-05-24 Md Bioalpha Co., Ltd. Composition having effect on treatment and prevention of diseases syndrome treatment with glabridin
TW200806306A (en) 2006-02-24 2008-02-01 Kaneka Corp Oil-in-water emulsion composition containing licorice-derived polyphenol
TW200808333A (en) 2006-04-17 2008-02-16 Kaneka Corp Licorice polyphenol preparation
GB0623838D0 (en) 2006-11-29 2007-01-10 Malvern Cosmeceutics Ltd Novel compositions
DE102006062264A1 (en) 2006-12-22 2008-06-26 Joh. Barth & Sohn Gmbh & Co. Kg Use of xanthohumol for the prevention and / or control of liver diseases
US9241893B2 (en) 2007-11-19 2016-01-26 Stiefel Laboratories, Inc. Topical cosmetic skin lightening compositions and methods of use thereof
CA2719799A1 (en) 2008-04-11 2009-10-15 Betal, Llc Xanthohumol compositions and methods for treating skin diseases or disorders
ES2316312B1 (en) 2008-06-20 2010-02-08 Ignacio Umbert Millet DERMATOLOGICAL PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF SKIN INFLAMMATION PATHOLOGIES, SUCH AS FOR EXAMPLE DERMATITIS, ATOPICA DERMATITIS, VITILIGO, AREATA ALOPECIA, ACNE, PSORIASIS AND PRURITO, AND COMBINATIONS OF THE SAME.
EP2192160B1 (en) 2008-12-01 2016-08-17 Aquanova Ag Micellar integrated oxidation protection for natural dyes
US20110086017A1 (en) 2009-10-08 2011-04-14 Svetlana Kravets Medical Food composition and methods for management of inflammatory processes in mammals
EP2662068B1 (en) 2011-01-06 2017-07-05 Kao Corporation Oil-in-water emulsion composition
WO2013009928A1 (en) * 2011-07-11 2013-01-17 Organic Medical Research Cannabinoid formulations
DE202012012130U1 (en) * 2012-12-19 2014-03-21 Aquanova Ag Curcuminsolubilisat
US10213391B2 (en) 2014-05-06 2019-02-26 Mewa Singh Pharmaceutical compositions comprising hemp and turmeric to treat pain and inflammation
US20160008298A1 (en) 2014-07-14 2016-01-14 Oregon State University Xanthohumol-based compounds and compositions thereof, and methods of making and using the same
WO2016022936A1 (en) 2014-08-07 2016-02-11 Murty Pharmaceuticals, Inc. An improved oral gastrointestinal dosage form delivery system of cannabinoids and/or standardized marijuana extracts
US20160081975A1 (en) * 2014-09-18 2016-03-24 Virun, Inc. Soft gel compositions and pre-gel concentrates
IL248149B (en) 2016-09-29 2020-03-31 Garti Nissim Dilutable formulations of cannbinoids and processes for their preparation
CN106619588B (en) * 2016-12-29 2019-08-16 厦门金达威生物科技有限公司 It is a kind of containing Co-Q10 from micro-emulsion type alimentation composition, Preparation method and use
GB2559774B (en) * 2017-02-17 2021-09-29 Gw Res Ltd Oral cannabinoid formulations
WO2019011415A1 (en) 2017-07-11 2019-01-17 Aquanova Ag Solubilisate with curcumin, xanthohumol and licorice root extract
CN111163806A (en) 2017-07-11 2020-05-15 阿奎诺瓦股份公司 Solubilized product comprising curcumin, boswellia and xanthohumol

Also Published As

Publication number Publication date
EP3651805A2 (en) 2020-05-20
HRP20231160T1 (en) 2024-01-05
RS64636B1 (en) 2023-10-31
WO2019011955A3 (en) 2019-05-16
WO2019011954A1 (en) 2019-01-17
RU2771527C1 (en) 2022-05-05
US11931322B2 (en) 2024-03-19
PL3651804T3 (en) 2024-01-03
HUE064518T2 (en) 2024-03-28
ES2960689T3 (en) 2024-03-06
WO2019011955A2 (en) 2019-01-17
CA3148455A1 (en) 2019-01-17
PL3820529T3 (en) 2024-01-03
CA3069621C (en) 2022-05-03
WO2019011990A1 (en) 2019-01-17
CN111201041A (en) 2020-05-26
HUE063768T2 (en) 2024-02-28
PT3651805T (en) 2023-12-22
CA3069621A1 (en) 2019-01-17
US20220133646A1 (en) 2022-05-05
DK3651804T3 (en) 2023-09-25
US20220133682A1 (en) 2022-05-05
UA125552C2 (en) 2022-04-13
MX2021000385A (en) 2021-03-25
DK3651805T3 (en) 2023-12-11
US20220125741A1 (en) 2022-04-28
US11197834B2 (en) 2021-12-14
HRP20231591T1 (en) 2024-03-15
JP2020529974A (en) 2020-10-15
DK3651804T5 (en) 2023-10-09
FI3820528T3 (en) 2023-10-17
US20200129452A1 (en) 2020-04-30
DK3820528T3 (en) 2023-10-16
EP3651804A1 (en) 2020-05-20
HUE063380T2 (en) 2024-01-28
HRP20231135T1 (en) 2024-01-05
US20220249400A1 (en) 2022-08-11
RU2752078C1 (en) 2021-07-22
ES2965739T3 (en) 2024-04-16
FI3651804T3 (en) 2023-10-04
US20200222346A1 (en) 2020-07-16
RS64642B1 (en) 2023-10-31
US11344509B2 (en) 2022-05-31
CN111163806A (en) 2020-05-15
ES2960296T3 (en) 2024-03-04
HUE063382T2 (en) 2024-01-28
PT3651804T (en) 2023-10-18
PL3651805T3 (en) 2024-04-08
MX2021000339A (en) 2021-03-25
BR112020000398A2 (en) 2020-07-14
KR20200029002A (en) 2020-03-17
EP3651805B1 (en) 2023-10-25
EP3651804B1 (en) 2023-08-23

Similar Documents

Publication Publication Date Title
EP3064523A4 (en) Copolycarbonate and composition comprising same
EP3239543A4 (en) Sliding bearing and pump
IL259570A (en) Combination treatments and uses and methods thereof
EP3131636A4 (en) Curcumin compositions and uses thereof
HUE063380T2 (en) Solubilisate with curcumin, boswellia, and xanthohumol
HK1244157A1 (en) Spectrum sharing architectures and methods
EP3045487A4 (en) Copolycarbonate and composition comprising same
PT3782617T (en) Pharmaceutical gel compositions comprising levodopa, carbidopa and entacapon
HK1244631A1 (en) Fruit and vegetable preservative
EP3178504A4 (en) Package and package assembly
EP3231289A4 (en) Oil-in-water type composition and food using same
EP3215163A4 (en) Beta-glucan methods and compositions that affect the tumor microenvironment
HK1258524A1 (en) Dual variable domain immunoconjugates and uses thereof
EP3275316A4 (en) Tien-cha extract essence and application therefor
EP3395391A4 (en) Guidewire-guiding device, and guidewire-guiding assembly
EP3050908A4 (en) Copolycarbonate and composition comprising same
EP3385577A4 (en) Shaft and seal structure
EP3092302A4 (en) Attenuated salmonella enterica
GB201700501D0 (en) Speaking valves, tracheostomy tubes and assemblies
GB201512817D0 (en) Bungs and airlock arrangements
RS64651B1 (en) Xanthohumol solubilisate
EP3050909A4 (en) Copolycarbonate and composition comprising same
IL271555A (en) Combination and uses and treatments thereof
TWM534192U (en) Clipping and conveying mechanism
GB2542851B (en) Container section and container comprising two container sections